General MedicationsORALGeneric

ABACAVIR SULFATE

Standard Dose

EQ 300MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 201570 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ABACAVIR SULFATE Form and strength TABLET;ORAL - EQ 300MG BASE Sponsor APOTEX INC Submission history Latest submission status date: 2021-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 201570 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ABACAVIR SULFATE Form and strength TABLET;ORAL - EQ 300MG BASE Sponsor APOTEX INC Submission history Latest submission status date: 2021-01-13 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.